WallStreetZenWallStreetZen

NASDAQ: MAZE
Maze Therapeutics Inc Stock Ownership - Who owns Maze Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maze Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason V. ColomaCEO2026-08-032,439$26.72
$65.16kSell
Jason V. ColomaCEO2026-08-031,604$27.09
$43.44kSell
Jason V. ColomaCEO2026-08-0330,304$26.71
$809.54kSell
Jason V. ColomaCEO2026-08-03154$27.09
$4.17kSell
Atul DandekarOfficer2026-07-297,100$27.31
$193.87kSell
Atul DandekarOfficer2026-07-297,500$10.42
$78.15kBuy
Atul DandekarOfficer2026-07-29400$27.89
$11.16kSell
Jason V. ColomaChief Executive Officer2026-07-012,593$29.98
$77.73kSell
Jason V. ColomaChief Executive Officer2026-07-011,597$30.44
$48.61kSell
Harold BernsteinPresident RD CMO2026-07-0113,409$29.87
$400.46kSell

1 of 11

MAZE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MAZE insiders and whales buy or sell their stock.

MAZE Shareholders

What type of owners hold Maze Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Third Rock Ventures IV LP9.77%5,424,758$149.34MInsider
Frazier Life Sciences Management LP8.22%4,567,274$125.74MInstitution
Trv GP IV LLC8.05%4,473,958$123.17MInstitution
Arch Venture Management LLC7.42%4,120,053$113.43MInstitution
Deep Track Capital LP6.26%3,477,562$95.74MInstitution
Janus Henderson Group PLC5.15%2,858,876$78.70MInstitution
Paradigm Biocapital Advisors LP4.94%2,744,399$75.55MInstitution
Blackrock Inc4.63%2,570,425$70.76MInstitution
A16z Capital Management LLC3.06%1,702,225$46.86MInstitution
Venrock Adviser LLC2.88%1,602,034$44.10MInstitution

1 of 3

MAZE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MAZE88.64%11.36%Net SellingNet Selling
VIR72.82%27.18%Net SellingNet Selling
SLBT0.22%0.68%
XERS57.70%13.49%Net SellingNet Selling
JBIO72.82%27.18%Net Buying
View Top Biotech Stocks

Maze Therapeutics Stock Ownership FAQ

Who owns Maze Therapeutics?

Maze Therapeutics (NASDAQ: MAZE) is owned by 93.03% institutional shareholders, 11.93% Maze Therapeutics insiders, and 0.00% retail investors. Third Rock Ventures IV LP is the largest individual Maze Therapeutics shareholder, owning 5.42M shares representing 9.77% of the company. Third Rock Ventures IV LP's Maze Therapeutics shares are currently valued at $150.08M.

If you're new to stock investing, here's how to buy Maze Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.